2021 annual financial data
Protagonist Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -394.29%.
Operating income was -125,845,000 USD and net income was -125,551,000 USD.
Operating cash flow was -107,865,000 USD.
Get free Protagonist Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 27,357,000 USD
- Operating income
- -125,845,000 USD
- Net income
- -125,551,000 USD
- Operating cash flow
- -107,865,000 USD